Cardiovascular Disease in the Elderly

  • Gary¬†Gerstenblith

Part of the Contemporary Cardiology book series (CONCARD)

Table of contents

  1. Front Matter
    Pages i-x
  2. Samer S. Najjar, Edward G. Lakatta
    Pages 1-50
  3. William Russell Hazzard
    Pages 51-77
  4. Susan J. Zieman, Beth R. Malasky
    Pages 79-102
  5. Beth R. Malasky, Joseph S. Alpert
    Pages 103-119
  6. Steven P. Schulman, Gary Gerstenblith
    Pages 121-140
  7. Stephen D. Wiviott, Christopher P. Cannon
    Pages 141-157
  8. Michael J. McWilliams, Eric J. Topol
    Pages 159-177
  9. David D. Yuh, William A. Baumgartner
    Pages 179-201
  10. Michael W. Rich
    Pages 203-230
  11. Milind Y. Desai, Gary Gerstenblith
    Pages 231-259
  12. Jonathan P. Piccini, Hugh Calkins
    Pages 261-300
  13. Emile R. Mohler III, William R. Hiatt
    Pages 301-318
  14. Janice B. Schwartz
    Pages 335-362
  15. Lofty L. Basta, W. Daniel Doty, Michael D. D. Geldart
    Pages 363-400
  16. Back Matter
    Pages 401-418

About this book

Introduction

As the number, availability, and often the invasiveness and associated risks of new cardiovascular treatments expands, health care providers are increasingly called upon to decide whether or not to recommend these therapies to the increasing numbers of older patients with cardiovascular disease. In Cardiovascular Disease in the Elderly, a panel of clinicians, researchers, and leaders in the field review and discuss the latest findings on the pathophysiology, diagnosis, and management of cardiovascular disease in the older patient. The authors explain the physiological changes associated with the normal aging process that may lead to the development of disease, to adverse consequences once disease develops, and which alter the risk-benefit equation for medical and other interventions designed to diagnose, assess, and treat cardiovascular disease. The focus is on particularly common syndromes in the elderly, including cardiac failure with normal ejection fraction, isolated systolic hypertension, and atrial fibrillation. Wherever possible, the authors take an evidence-based approach to recommendations and rely heavily on prospective clinical trials. The value of lifestyle changes in the aging population, the use of primary and secondary prevention strategies, and the treatment of acute and chronic ischemic disease and its complications are also discussed.
Comprehensive and authoritative, Cardiovascular Disease in the Elderly offers physicians and other providers who care for the older patient a gold-standard approach to understanding and managing cardiovascular disease in this group.

Keywords

atrial fibrillation cardiovascular coronary artery disease heart hypertension rehabilitation vascular disease

Editors and affiliations

  • Gary¬†Gerstenblith
    • 1
  1. 1.Johns Hopkins University School of MedicineBaltimore

Bibliographic information

  • DOI https://doi.org/10.1385/1592599419
  • Copyright Information Humana Press Inc. 2005
  • Publisher Name Humana Press
  • eBook Packages Medicine
  • Print ISBN 978-1-58829-282-7
  • Online ISBN 978-1-59259-941-7
  • About this book
Industry Sectors
Biotechnology
Pharma